The real risks of angel investing, explained honestly.

The biggest risk in angel investing is simple: most early-stage companies fail, and you can lose every pound you put into any one of them. The rest - illiquidity, dilution, the limits of tax relief, the odd fraud - are the texture around that central fact. Here they are, without the founder gloss.

The pitch for angel investing tends to skate over the part that matters most. You hear about the founder who turned a £10,000 cheque into a life-changing return, and far less about the nine other cheques the same investor wrote that quietly went to zero. Both halves of that story are true. The trouble is that only one of them gets told at dinner.

So here is the unglamorous version - not a reason for or against putting money into early-stage companies, but the risk baked into the asset class, laid out so you can see it before, rather than after, the money has gone.

The winners get the anecdotes. The losses get the silence.

Can you lose all your money?

Yes, and on any single investment it's the most likely outcome. This is the risk everything else hangs off. When you back a young private company you're buying shares that may become worthless, and unlike a listed stock there's rarely a slow slide you can watch and exit. More often the company simply runs out of cash, the shares are written off, and the capital is gone.

The numbers behind early-stage portfolios are blunt about this. Across most studies of angel and seed returns, the majority of companies return less than the money put in, and a large slice return nothing at all. The whole model leans on a few outsized winners doing the heavy lifting for everything that failed. That only works if you hold enough companies for the maths to play out - and even then, no spread guarantees a winner turns up.

A sensible working assumption is that any individual cheque could go to zero - and if a single failure would genuinely hurt your finances, the structure of this asset class is worth sitting with before anything else.

Why can't you get your money out?

Even when a company is doing fine, your money is stuck. Angel shares are illiquid - there's no public market, no daily price, and usually no one waiting to buy them off you. You can't decide in year two that you'd like the cash back and sell at Tuesday's close, because there is no Tuesday's close.

Money comes back only at a liquidity event: most commonly a trade sale, where a larger company buys the business, or, far more rarely, a flotation. These run on the company's timeline, not yours. A successful early-stage company often takes five to ten years to reach an exit, and plenty never do. The realistic stance is to treat the capital as locked away the moment it leaves your account.

What about dilution and concentration?

Two quieter risks tend to surprise newer angels, because neither announces itself the way a failure does.

The first is dilution. Every time a company raises a new round, it issues new shares - and your slice of the company gets thinner. Back something at seed and sit out the Series A, B and C, and the stake you started with can be a fraction of its original size by the time of an exit. The company can grow handsomely while your percentage of it shrinks, which means your eventual return depends as much on what happens in later rounds as on the cheque you wrote first.

The second is concentration. Because returns are so lumpy, a portfolio built around one or two bets behaves completely differently from one spread across many. Put most of your early-stage capital into a single company and you've tied your outcome to the least predictable thing in the room. The irony is that the way investors usually manage the total-loss risk - spreading bets - is exactly the discipline that's hardest to hold when one company looks especially exciting.

Doesn't SEIS and EIS relief cover the downside?

Partly, and this is where a lot of wishful thinking creeps in. The HMRC venture capital schemes are designed to soften losses, not to prevent them - they change the cost of a bad outcome, not the odds of one.

The Seed Enterprise Investment Scheme (SEIS) offers 50% income tax relief on up to £200,000 invested per tax year, with a three-year minimum holding period, loss relief if the company fails, and the option to carry relief back to the prior year. The Enterprise Investment Scheme (EIS) offers 30% income tax relief on up to £1,000,000 per tax year - or £2,000,000 if at least £1,000,000 goes into knowledge-intensive companies (broadly, those doing heavy R&D) - again with a three-year hold and loss relief. Both can return a meaningful chunk of a failed investment through the combination of upfront relief and loss relief.

But the relief only works if the conditions do. You generally have to be a UK taxpayer with enough income tax to set the relief against. The company has to keep its qualifying status for the whole holding period - lose it, and the relief can be clawed back. You need the company to issue valid SEIS3 or EIS3 certificates, and the schemes rely on HMRC advance assurance being in place before the round. The company-side EIS limits - gross assets of up to £30 million before the share issue (£35 million immediately after), a £10 million annual raise cap across the venture capital schemes, a £24 million lifetime cap, fewer than 250 full-time-equivalent employees, and shares issued within seven years of the first commercial sale - changed from 6 April 2026, and knowledge-intensive companies get higher ceilings. Because these rules move, check the current numbers in HMRC's guidance: gov.uk venture capital schemes (EIS).

For completeness, VCTs - Venture Capital Trusts, the listed fund route - carry 20% income tax relief on up to £200,000 a year, a five-year minimum hold, tax-free dividends and no CGT on gains, but no loss relief at all. The broader point holds across all three: relief reduces the sting of a loss for a qualifying UK taxpayer. It never turns a failing company into a good one. The full investor detail sits in the HMRC guidance for investors.

What about bad information and outright fraud?

At seed stage you're making a decision on thin evidence. There's rarely much trading history, the financial model is a set of hopeful assumptions, and you're largely betting on people you've known for a matter of weeks. That information gap is a risk in itself: you can do careful diligence and still be wrong, because the data to be right simply doesn't exist yet.

Then there's the rarer but real tail: misrepresentation and fraud. Founders occasionally overstate traction, revenue or commitments from other investors. The companies you back are largely unregulated, so the protections you'd associate with public markets aren't there. What is regulated is how these shares are marketed to you - under FCA rules, firms can only promote high-risk unlisted investments to people who self-certify as high-net-worth or sophisticated investors. That gateway exists precisely because the regulator treats this as a place where ordinary consumer safeguards don't apply.

Are there risks people forget?

A few that don't make the headline list but bite in practice:

None of this is a verdict. Plenty of people accept these risks with their eyes open and build early-stage portfolios deliberately. The honest framing is just that the risk is the headline feature of the asset class, not a footnote to it - and that the tax reliefs, useful as they are, work on the cost of being wrong rather than the chance of it. What you do with that is yours to decide, ideally with regulated advice.

Frequently asked questions

How likely am I to lose money angel investing?

Loss is the normal outcome for any single angel investment. Studies of early-stage portfolios consistently find that the majority of companies return less than the capital put in, and a large share return nothing at all. The model only works at the portfolio level, where a few outsized winners are meant to outweigh the many that fail. There is no guarantee a portfolio produces a winner, and you can lose your entire stake in any one company.

Does SEIS or EIS tax relief remove the risk?

No. SEIS and EIS reduce the cost of a loss; they do not reduce the chance of one. SEIS gives 50% income tax relief and EIS gives 30%, both with loss relief if the company fails, but relief only has value if you are a UK taxpayer with enough tax to set it against, if the company keeps its qualifying status for the three-year minimum holding period, and if you actually hold valid SEIS3 or EIS3 certificates. The shares themselves can still go to zero.

Why can't I sell angel shares when I want to?

Shares in private early-stage companies are illiquid. There is no public market, no daily price and usually no ready buyer. Money typically comes back only at an exit such as a trade sale, which can take five to ten years if it happens at all. Treating the capital as locked away, rather than as something you might need back, is the realistic stance.

What is dilution and why does it matter to an angel?

Dilution is the shrinking of your ownership percentage each time the company issues new shares to raise more money. An early angel who does not invest in later rounds can see a meaningful stake reduced to a small one by the time of an exit. The company can grow in value while your slice of it gets thinner, so the size of your eventual return depends as much on later rounds as on your original cheque.

Is angel investing in the UK regulated?

The companies themselves are largely unregulated, but how their shares are marketed to you is. Under FCA rules, firms can only promote these high-risk, unlisted investments to people who self-certify as high-net-worth or sophisticated investors. SEIS and EIS reliefs are administered by HMRC, not the FCA. This article is general information, not financial or investment advice; consider taking FCA-regulated advice before you invest.

Subscribe

Get The Carry every Wednesday.

Free. One email a week. About six minutes. Read by 60+ active UK angel investors.

Free · 6-minute read · Every Wednesday

One-click unsubscribe. We never sell subscriber data.

Share

More from The Carry

Related reads.

All essentials →